LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - Maze Therapeutics (NASDAQ: MAZE)

Follow NASDAQ:MAZE Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ MAZE Maze Therapeutics
Hoppenot Herve / director
10/06/2025
Buy
$27.52
36,000
$991K
36,000
NASDAQ MAZE Maze Therapeutics
SPIEGELMAN DANIEL K / director
09/22/2025
Buy
$23.67
18,000
$426K
18,000
NASDAQ MAZE Maze Therapeutics
Sohn Catherine A. / director
09/22/2025
Buy
$23.67
18,000
$426K
18,000
NASDAQ MAZE Maze Therapeutics
SCHELLER RICHARD H / director
09/22/2025
Buy
$23.67
18,000
$426K
18,000
NASDAQ MAZE Maze Therapeutics
Lim Jonathan E / director
09/22/2025
Buy
$23.67
18,000
$426K
18,000
NASDAQ MAZE Maze Therapeutics
Kathiresan Sekar / director
09/22/2025
Buy
$23.67
18,000
$426K
18,000
NASDAQ MAZE Maze Therapeutics
HOMCY CHARLES J / director
09/22/2025
Buy
$23.67
18,000
$426K
18,000
NASDAQ MAZE Maze Therapeutics
Exter Neil / director
09/22/2025
Buy
$23.67
18,000
$426K
18,000
NASDAQ MAZE Maze Therapeutics
Andrews Nancy C / director
09/22/2025
Buy
$23.67
18,000
$426K
18,000
NASDAQ MAZE Maze Therapeutics
SCHELLER RICHARD H / director
09/15/2025
Sell
$22.37
20,744
$464K
0
NASDAQ MAZE Maze Therapeutics
Tahir Misbah / officer: Chief Financial Officer
09/02/2025
Buy
$15.32
325,000
$4.979M
325,000

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous